BioMerieux Total Liabilities 2017-2024 | BMXMF

BioMerieux total liabilities from 2017 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
  • BioMerieux total liabilities for the quarter ending December 31, 2024 were $1.687B, a 3.79% increase year-over-year.
  • BioMerieux total liabilities for 2024 were $1.687B, a 3.43% increase from 2023.
  • BioMerieux total liabilities for 2023 were $1.631B, a 0.29% increase from 2022.
  • BioMerieux total liabilities for 2022 were $1.626B, a 4.68% decline from 2021.
BioMerieux Annual Total Liabilities
(Millions of US $)
2024 $1,687
2023 $1,631
2022 $1,626
2021 $1,706
2020 $1,652
2019 $1,711
2018 $1,637
2017 $1,417
2016 $1,557
2015 $0
BioMerieux Quarterly Total Liabilities
(Millions of US $)
2024-12-31 $1,687
2023-12-31 $1,631
2023-06-30 $1,515
2022-12-31 $1,626
2022-06-30 $1,625
2021-12-31 $1,706
2021-06-30 $1,697
2020-12-31 $1,652
2019-12-31 $1,711
2019-06-30 $1,720
2018-12-31 $1,637
2018-06-30 $1,394
2017-12-31 $1,417
2017-06-30 $1,412
2016-12-31 $1,557
Sector Industry Market Cap Revenue
Medical Medical Services $16.861B $4.307B
bioM?rieux S.A. designs, develops, manufactures and markets systems in the field of vitro diagnostics. The company provides diagnostic solutions which determine the source of disease and contamination. It also offers solutions for managing infectious diseases, cancers and cardiovascular diseases in clinical applications. The company provides solutions for the enumeration of microbial flora, detection of specific pathogenic bacteria, monitoring of air and surface quality and sterility testing for the agri-food, cosmetics and pharmaceutical industries. bioM?rieux S.A. is based in Marcy L Etoile, France.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $143.821B 26.97
CVS Health (CVS) United States $84.326B 10.48
Elevance Health (ELV) United States $78.255B 10.10
Cencora (COR) United States $58.178B 20.24
DiDi Global (DIDIY) China $23.485B 24.95
Natera (NTRA) United States $22.086B 0.00
Labcorp Holdings (LH) United States $21.684B 17.59
EUROFINS SCIENT (ERFSF) Luxembourg $13.804B 0.00
Solventum (SOLV) United States $12.836B 13.59
CochLear (CHEOY) Australia $12.824B 0.00
ICON (ICLR) Ireland $12.156B 11.30
Revvity (RVTY) United States $11.802B 20.31
Viatris (VTRS) United States $10.833B 3.72
Avantor (AVTR) United States $9.247B 13.44
Medpace Holdings (MEDP) United States $9.225B 24.50
HealthEquity (HQY) United States $8.646B 37.87
Sonic Healthcare (SKHHY) Australia $8.518B 0.00
Charles River Laboratories (CRL) United States $7.808B 15.30
Caris Life Sciences,�Inc (CAI) United States $6.930B 0.00
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $4.971B 29.27
BrightSpring Health Services (BTSG) United States $3.760B 34.50
Sotera Health (SHC) United States $3.296B 18.73
Surgery Partners (SGRY) United States $2.870B 37.32
Alignment Healthcare (ALHC) United States $2.750B 0.00
GeneDx Holdings (WGS) United States $2.622B 100.97
Concentras Parent (CON) United States $2.619B 15.13
Organon (OGN) United States $2.576B 2.74
Progyny (PGNY) United States $2.038B 44.87
Ardent Health (ARDT) United States $1.981B 8.45
PACS (PACS) United States $1.957B 0.00
Premier (PINC) United States $1.778B 13.49
GoodRx Holdings (GDRX) United States $1.739B 34.79
Teladoc Health (TDOC) United States $1.553B 0.00
Establishment Labs Holdings (ESTA) $1.303B 0.00
Pediatrix Medical (MD) United States $1.165B 8.86
CareDx (CDNA) United States $1.129B 17.64
Ryman Healthcare (RYHTY) New Zealand $0.970B 0.00
Agilon Health (AGL) United States $0.948B 0.00
QDM (QDMI) Hong Kong, SAR China $0.846B 0.00
AMN Healthcare Services Inc (AMN) United States $0.833B 7.80
Nutex Health (NUTX) United States $0.643B 9.73
Embecta (EMBC) United States $0.619B 4.17
InnovAge Holding (INNV) United States $0.571B 0.00
SBC Medicals (SBC) United States $0.546B 0.00
LifeMD (LFMD) United States $0.535B 0.00
Sonida Senior Living (SNDA) United States $0.484B 0.00
Auna S.A (AUNA) Luxembourg $0.471B 10.62
So-Young (SY) China $0.440B 0.00
Omada Health (OMDA) $0.434B 0.00
Enhabit (EHAB) United States $0.368B 30.29
Performant Healthcare (PHLT) United States $0.335B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.330B 0.00
Beauty Health (SKIN) United States $0.263B 0.00
Oncology Institute (TOI) United States $0.216B 0.00
DocGo (DCGO) United States $0.159B 26.00
Pheton Holdings (PTHL) China $0.132B 0.00
Sera Prognostics (SERA) United States $0.100B 0.00
KindlyMD (NAKA) United States $0.074B 0.00
Basel Medical Group (BMGL) Singapore $0.067B 0.00
IceCure Medical (ICCM) Israel $0.062B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
ModivCare (MODV) United States $0.060B 0.00
Biodesix (BDSX) United States $0.046B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.037B 0.00
OSR Holdings (OSRH) United States $0.024B 0.00
Intelligent Bio Solutions (INBS) United States $0.013B 0.00
BioNexus Gene Lab (BGLC) $0.010B 0.00
Co-Diagnostics (CODX) United States $0.009B 0.00
SeaStar Medical Holding (ICU) United States $0.008B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00